Eksisterende data tyder på, at det ikke er nødvendigt at justere dosen af Xolair hos patienter i etableret hyposensibiliseringsbehandling.
Current data suggest that no dose adjustments of Xolair are needed in patients on established hypo-sensitisation therapy.